Mouse Aurora A: expression in Escherichia coli and purification

Area of Science:

• Molecular Biology
• Biochemistry
• Oncology

Background:

• Aurora kinases are key targets for small-molecule inhibitors in cancer therapy.
• Current methods for producing active Aurora-A protein often use insect cells or yield impaired proteins from E. coli.
• Efficient production of active Aurora-A is crucial for developing new cancer drugs.

Purpose of the Study:

• To present a novel method for expressing large quantities of active mouse Aurora-A kinase domain in bacteria.
• To outline a straightforward purification protocol for obtaining highly pure active mouse Aurora-A.
• To provide a simplified approach for producing difficult-to-express kinases in prokaryotic systems.

Main Methods:

• Expression of mouse Aurora-A kinase domain as an N-terminal glutathione-S-transferase (GST) fusion protein in bacteria.
• Development of a simple purification strategy for the GST-Aurora-A fusion protein.
• Assessment of protein purity using biochemical assays and suitability for X-ray crystallography.

Main Results:

• Successful expression of large quantities of active mouse Aurora-A kinase domain in bacteria.
• A purification method yielding >99% pure protein samples was established.
• The purified protein is suitable for enzymatic assays and X-ray crystallography.

Conclusions:

• The described method simplifies the expression and purification of active mouse Aurora-A kinase in prokaryotes.
• This approach may facilitate the production of other challenging kinase proteins.
• The findings support the ongoing development of Aurora kinase inhibitors for oncology.